Author: Kim Gear, Oral Medicine Trainee, Auckland, New Zealand, 2007. Updated by A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand. January 2018. Minor amendment by Ian Coulson. July 2024.
Oral lichen planus is lichen planus inside the mouth. Lichen planus is a chronicinflammatory skin condition.
Reticular lichen planus
Erosive lichen planus
Plaque lichen planus
Who gets oral lichen planus?
Lichen planus affects about 1–2% of the adult population. It usually affects adults older than 45 years, with an average age at diagnosis of 50–60 years, although it may affect younger adults and children. It is more common in women than in men (1.4: 1). A history of lichen planus in family members is sometimes present.
Oral lichen planus affects 50% of patients with cutaneouslichen planus but may occur without skin lesions elsewhere.
What is the cause of oral lichen planus?
The precise cause of oral lichen planus is not fully understood. It involves cytotoxic CD8+ T lymphocytes and pro-inflammatory cytokines, which attack the oral epithelial cells — resulting in their death. The immune response is mediated by antigen-specific cells.
In most cases oral lichen planus is idiopathic, when the reaction is thought to be against autoantigens. In other cases, it may be precipitated by exogenousantigens described below.
May be associated with erosive lichen planus affecting genital sites
Plaque type oral lichen planus
Usually seen in smokers
Confluent white patches similar to oral keratoses
Reticular pattern
Erosive pattern
Plaque pattern
How is the diagnosis of oral lichen planus made?
The diagnosis of oral lichen planus is often made by its clinical appearance. Tissue biopsy may be helpful, when characteristic features of lichen planus may be observed. Biopsy can help exclude other oral conditions with lichenoid reaction, such as drug-induced lichenoid reaction, oral lupus erythematosus, or a contact lichenoid reaction.
Oral lichen planus can be very painful and ulceration may lead to scarring. Sometimes eating is so uncomfortable that the affected person is unable to maintain adequate nutrition.
Lichen planus, particularly the erosive form, may rarely lead to oral cancer (squamous cell carcinoma). Persistentulcers and enlarging nodules should undergo biopsy.
Oral lichen planus and squamous cell carcinoma
Alveolar cancer
Management of oral lichen planus
It is important to identify and remove or avoid any potential agent that might have caused a lichenoid reaction, such as drugs that have been started in recent months and contact allergens identified by patch testing.
Most people get satisfactory control of symptoms with the following measures.
Meticulous oral hygiene: brushing teeth and gums, regular visits to dentist, once-weekly mouthwash with diluted chlorhexidine or benzydamine
If standard toothpaste irritates, try products that do not contain sodium lauryl sulphate
Topical steroids as drops, pastes, gels or sprays, for example, triamcinolone in an emollient dental paste, fluticasone nasal preparations, and clobetasol propionate in various forms. Topical steroids can be delivered to oral lichen planus affecting the gums within a polyvinyl siloxane medication tray, held in place for a couple of hours.
Targeted molecular medicines are under investigation for the treatment or recalcitrant disease, with apremilast reported effective in a few patients.
What is the outcome of lichen planus?
The prognosis for oral lichen planus is uncertain. It can clear up within a few months or persist (with or without treatment) for decades. There are often periods of remission and relapse.
References
Lopez Jornet, P. and Aznar-Cayuela, C. (2016), Efficacy of topical chamomile management vs. placebo in patients with oral lichen planus: a randomized double-blind study. J Eur Acad Dermatol Venereol, 30: 1783–1786. doi:10.1111/jdv.13770. Journal.
Bettencourt M. Oral Lichen Planus Treated With Apremilast. J Drugs Dermatol. 2016 Aug 1;15(8):1026–8. PubMed PMID: 27538007. PubMed.
Thanyavuthi A, Boonchai W, Kasemsarn P. Amalgam Contact Allergy in Oral Lichenoid Lesions. Dermatitis. 2016 Jul-Aug;27(4):215–21. doi: 10.1097/DER.0000000000000204. PubMed PMID: 27323234.PubMed.
Singh AR, Rai A, Aftab M, Jain S, Singh M. Efficacy of steroidal vs non-steroidal agents in oral lichen planus: a randomised, open-label study. J Laryngol Otol. 2017 Jan;131(1):69–76. Epub 2016 Dec 5. PubMed PMID: 27917729. PubMed.
Nogueira PA, Carneiro S, Ramos-e-Silva M. Oral lichen planus: an update on its pathogenesis. Int J Dermatol. 2015 Sep;54(9):1005–10. doi: 10.1111/ijd.12918. Epub 2015 Jul 3. Review. PubMed PMID: 26147778. PubMed.
Krupaa RJ, Sankari SL, Masthan KM, Rajesh E. Oral lichen planus: An overview. J Pharm Bioallied Sci. 2015 Apr;7(Suppl 1):S158–61. doi: 10.4103/0975-7406.155873. Review. PubMed PMID: 26015696; PubMed Central PMCID: PMC4439656. PubMed Central.
Saeed S, Choudhury P, Ahmad SA, et al. Vitamin D in the Treatment of Oral Lichen Planus: A Systematic Review. Biomedicines. 2022;10(11):2964. Published 2022 Nov 17. doi:10.3390/biomedicines10112964 PubMed
Vinay K, Kumar S, Dev A, et al. Oral Acitretin Plus Topical Triamcinolone vs Topical Triamcinolone Monotherapy in Patients With Symptomatic Oral Lichen Planus: A Randomized Clinical Trial. JAMA Dermatol. 2024;160(1):80–7. PubMed